Genistein, a competitive PDE1–4 inhibitor, may bind on high-affinity rolipram binding sites of brain cell membranes and then induce gastrointestinal adverse effects

陳健民CH, ShihShihCHLH, LinLinLHYH, LaiLaiYHCY, LaiLaiCYCY, HanHanCYCM, ChenChenCMWC, KoKoWC2026-06-052026-06-052010https://203.71.86.71/handle/123456789/49872醫學檢驗暨生物技術學系期刊論文Genistein, a competitive PDE1–4 inhibitor, may bind on high-affinity rolipram binding sites of brain cell membranes and then induce gastrointestinal adverse effectsarticle